Home › Attention Deficit Hyperactivity Disorder › Pennsylvania › Harrisburg
Attention Deficit Hyperactivity Disorder clinical trials in Harrisburg, PA
3 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Harrisburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Penn State Health Medical Group - Psychiatry and Behavioral Health, Hershey · 12 mi away
Impact of Parental Emotion Regulation on the Treatment of ADHD
Recruiting
- Penn State Health Dept of Psychiatry, Hershey · 12 mi away
Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants
RecruitingPhase 4
- Penn State Health Dept of Psychiatry, Hershey · 12 mi away
About Attention Deficit Hyperactivity Disorder
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Philadelphia, PA6 studies
- Austin, TX6 studies
- Washington, DC5 studies
- Pittsburgh, PA5 studies
- Orlando, FL5 studies
- Las Vegas, NV5 studies
- New York City, NY4 studies
- Memphis, TN4 studies
- Baltimore, MD4 studies
- Los Angeles, CA4 studies
Other studies in Harrisburg
- Heart Failure14 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer12 studies
- Cardiovascular Disease11 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Colorectal Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- High Blood Pressure6 studies
- Crohn's Disease6 studies
- Neuroblastoma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.